Nootropic peptides represent one of the most rapidly advancing areas of cognitive neuroscience research. Unlike synthetic racetams or stimulant-based compounds, peptide nootropics work through endogenous signalling pathways — BDNF upregulation, GABAergic modulation, and direct neuropeptide receptor activation. This guide covers the three most well-characterised nootropic peptides available in India: Semax, Selank, and Pinealon.
Why Peptide Nootropics Are Different
Most small-molecule cognitive enhancers (caffeine, modafinil, racetams) act on monoamine systems — dopamine, norepinephrine, acetylcholine. They produce tolerance and often rebound effects. Nootropic peptides, by contrast, modulate neuroplasticity factors like BDNF and NGF, regulate inhibitory/excitatory balance, and interact with circadian and neuroendocrine systems. The result is a mechanistically distinct and, in many respects, more elegant research approach to cognitive enhancement. Explore the full range of brain peptides available in India.
Semax — BDNF Upregulation & Cognitive Enhancement
Semax is a heptapeptide analogue of ACTH(4-7), developed in Russia and approved there for clinical use in stroke recovery and cognitive disorders. Its primary mechanism in research models is pronounced upregulation of Brain-Derived Neurotrophic Factor (BDNF) and Nerve Growth Factor (NGF) — proteins essential for synaptic plasticity, long-term potentiation, and neuronal survival.
Semax also modulates serotonin and dopamine receptor expression and displays neuroprotective effects against ischaemic injury. Research dosing is 300–600 mcg/day intranasally, or 100–300 mcg subcutaneous. The intranasal route is particularly studied due to direct nose-to-brain transport bypassing the blood-brain barrier. Cycles of 2–4 weeks on, 2 weeks off are common in research protocols.
Selank — Anxiolysis, Focus & Immune Modulation
Selank is a synthetic hexapeptide analogue of the endogenous immunomodulatory peptide tuftsin, developed by the Russian Institute of Molecular Genetics. It exerts anxiolytic effects via GABAergic potentiation — a mechanism similar to benzodiazepines but without sedation, tolerance, or withdrawal. In research models, Selank also upregulates BDNF and modulates IL-6 and interferon expression, positioning it uniquely at the intersection of anxiety, cognitive function, and immune research.
Selank research dosing is 250–500 mcg/day intranasally, typically administered as two divided doses. Many researchers pair Semax (BDNF/focus) with Selank (anxiolysis/mood stability) for a complementary cognitive stack. Both are available from the brain peptides catalogue.
Pinealon — Cognition, Sleep & Epigenetic Regulation
Pinealon is a tripeptide (Glu-Asp-Arg) derived from the pineal gland, part of the Khavinson short peptide class developed at the St. Petersburg Institute of Bioregulation. Its primary research interest lies in epigenetic regulation — Pinealon has been shown to modulate gene expression in neural and retinal tissue, improving cognitive function, reducing oxidative stress markers, and significantly improving sleep architecture in aged animal models.
Research dosing for Pinealon is 5–10 mcg/day subcutaneous or intranasal, making it one of the lowest-dose research peptides in use. Its sleep-improving properties (via melatonin pathway interaction) make it a natural companion to circadian rhythm and cognitive ageing research. Before reconstituting, use the BAC Water Calculator to ensure accurate concentration at these micro-dose levels.
Stacking Nootropic Peptides
The most studied nootropic peptide combination is Semax + Selank. Semax provides the excitatory, focus-enhancing, BDNF-driven component; Selank provides the calming, anxiolytic, anti-inflammatory balance. Adding Pinealon at night leverages circadian and epigenetic pathways that the other two do not touch. This three-peptide stack covers BDNF upregulation, GABAergic anxiety modulation, and circadian/epigenetic optimisation simultaneously.
Sourcing Nootropic Peptides in India
Intranasal peptide research is particularly sensitive to purity — contaminants delivered directly to the olfactory bulb are a real concern. Peptide Central stocks Semax, Selank, and Pinealon with 99% HPLC purity, COA on every batch, and pan-India COD delivery. All products are for in-vitro and research use only.